Additional support for schizophrenia linkage on chromosomes 6 and 8: A multicenter study

Dieter B. Wildenauer(University of Bonn), Sibylle G. Schwab(University of Bonn), Margot Albus, Joachim Hallmayer(The University of Western Australia), Bernard Lerer(Hadassah Medical Center), Wolfgang Maier(University of Bonn), Douglas Blackwood(Western General Hospital), Walter Muir(Western General Hospital), David St Clair(Western General Hospital), Stewart W. Morris(Western General Hospital), Hans W. Moises(Christian-Albrechts-Universität zu Kiel), Yang Liu(Christian-Albrechts-Universität zu Kiel), Helgi Kristbjarnarson(National University Hospital), Tómas Helgason(National University Hospital), Claudia Wiese(Christian-Albrechts-Universität zu Kiel), David Collier(Hologic (Germany)), Peter Holmans(University of Wales), Jo Daniels(University of Wales), Mark I. Rees(University of Wales), Philip Asherson(University of Wales), Queta Roberts(University of Wales), Alastair G. Cardno(University of Wales), María J. Arranz(Hologic (Germany)), Homero Vallada(Hologic (Germany)), David Ball(Hologic (Germany)), Hiroshi Kunugi(Hologic (Germany)), Robin Murray(Hologic (Germany)), John Powell(Hologic (Germany)), S. Nanko(Teikyo University), Pak C. Sham(Hologic (Germany)), Mike Gill(St. James's Hospital), Peter McGuffin(University of Wales), Michael J. Owen(University of Wales), Ann E. Pulver(Johns Hopkins University), Stylianos E. Antonarakis(University of Geneva), Robert Babb(Johns Hopkins University), J L Blouin(University of Geneva), Nicola DeMarchi(University of Naples Federico II), Beth A. Dombroski(University of Pennsylvania), David E. Housman(Center for Cancer Research), Maria Karayiorgou(Rockefeller University), Jürg Ott(Rockefeller University), Laura Kasch(Johns Hopkins University), Haig H. Kazazian(University of Pennsylvania), Virginia K. Lasseter(Johns Hopkins University), Erika Loetscher(Novartis (Switzerland)), H. Luebbert(Sanden (Japan)), Gerald Nestadt(Johns Hopkins University), Carl C.T. Ton(Center for Cancer Research), Paula Wolyniec(Johns Hopkins University), Claudine Laurent(Centre National de la Recherche Scientifique), Michel de Chaldée(Centre National de la Recherche Scientifique), Florence Thibaut(Centre d’histoire sociale des mondes contemporains), Maurice Jay(Centre d’histoire sociale des mondes contemporains), Danièle Samolyk(Centre National de la Recherche Scientifique), Michel Petit(Centre d’histoire sociale des mondes contemporains), Dominique Campion(Centre d’histoire sociale des mondes contemporains), Jacques Mallet(Centre National de la Recherche Scientifique), Richard E. Straub(Virginia Commonwealth University Medical Center), Charles J. MacLean(Virginia Commonwealth University Medical Center), Stephen M. Easter(Virginia Commonwealth University Medical Center), F. Anthony O’Neill(Queen's University Belfast), Dermot Walsh(Health Research Board), Kenneth S. Kendler(Virginia Commonwealth University Medical Center), Pablo V. Gejman(National Institute of Mental Health), Qiuhe Cao(National Institute of Mental Health), Elliot S. Gershon(National Institute of Mental Health), Judith A. Badner(National Institute of Mental Health), Ethiopia Beshah(National Institute of Mental Health), Jing Zhang(National Institute of Mental Health), Brien P. Riley(St. Mary's Hospital), Swarnageetha Rajagopalan(St. Mary's Hospital), Mpala Mogudi-Carter(Chris Hani Baragwanath Hospital), Trefor Jenkins(University of the Witwatersrand), Robert Williamson(St. Mary's Hospital), Lynn E. DeLisi(Stony Brook University), Chad Garner(Fate Therapeutics (United States)), Mary Margaret Kelly(Fate Therapeutics (United States)), Carrie LeDuc(Fate Therapeutics (United States)), Lon R. Cardon(Fate Therapeutics (United States)), Jay B. Lichter(Fate Therapeutics (United States)), Tim Harris(Fate Therapeutics (United States)), J. Loftus(Warneford Hospital), Gail Shields(Stony Brook University), Margarite Comasi(University of Milan), Antonio Vita(University of Milan), Angela Smith(Stony Brook University), J.C. Dann(Warneford Hospital), Geoff Joslyn(Fate Therapeutics (United States)), Hugh Gurling(University College London), Gursharan Kalsi(University College London), Jon Brynjolfsson(University of Iceland), David Curtis(Royal London Hospital), Thordur Sigmundsson(University College London), Robert J. Butler(University College London), Tim Read(University College London), Patrice Murphy(University College London), Andrew Chih-Hui Chen(University College London), Hannes Pétursson(University of Iceland), Bill Byerley(University of Utah), Mark Hoff(University of Utah), John Holik(University of Utah), Hilary Coon(University of Utah), Douglas F. Levinson(Allegheny College), Derek J. Nancarrow(The University of Queensland), Raymond R. Crowe(University of Iowa), Nancy C. Andreasen(University of Iowa), Jeremy M. Silverman, Richard C. Mohs, Larry J. Siever, Jean Endicott(New York Psychoanalytic Society and Institute), Lawrence Sharpe(New York Psychoanalytic Society and Institute), Marilyn K. Walters(QIMR Berghofer Medical Research Institute), David P. Lennon(The University of Queensland), Nicholas K. Hayward(QIMR Berghofer Medical Research Institute), Lodewijk A. Sandkuijl(University of Groningen), Bryan Mowry(The University of Queensland), H.N. Aschauer(Vienna General Hospital), K. Meszaros(Vienna General Hospital), E. Lenzinger(Vienna General Hospital), Karoline Fuchs(Vienna General Hospital), Yang Liu(Christian-Albrechts-Universität zu Kiel), A. Heiden(Vienna General Hospital), Hans W. Moises(Christian-Albrechts-Universität zu Kiel), Leonid Kruglyak(Whitehead Institute for Biomedical Research), Mark Daly(Whitehead Institute for Biomedical Research), Tara C. Matise(Columbia University)
American Journal of Medical Genetics
November 22, 1996
Cited by 186

Abstract

In response to reported schizophrenia linkage findings on chromosomes 3, 6 and 8, fourteen research groups genotyped 14 microsatellite markers in an unbiased, collaborative (New) sample of 403-567 informative pedigrees per marker, and in the Original sample which produced each finding (the Johns Hopkins University sample of 46-52 informative pedigrees for chromosomes 3 and 8, and the Medical College of Virginia sample of 156-191 informative pedigrees for chromosome 6). Primary planned analyses (New sample) were two-point heterogeneity lod score (lod2) tests (dominant and recessive affected-only models), and multipoint affected sibling pair (ASP) analysis, with a narrow diagnostic model (DSM-IIIR schizophrenia and schizoaffective disorders). Regions with positive results were also analyzed in the Original and Combined samples. There was no evidence for linkage on chromosome 3. For chromosome 6, ASP maximum lod scores (MLS) were 2.19 (New sample, nominal p = 0.001) and 2.68 (Combined sample, p = .0004). For chromosome 8, maximum lod2 scores (tests of linkage with heterogeneity) were 2.22 (New sample, p = .0014) and 3.06 (Combined sample, p = .00018). Results are interpreted as inconclusive but suggestive of linkage in the latter two regions. We discuss possible reasons for failing to achieve a conclusive result in this large sample. Design issues and limitations of this type of collaborative study are discussed, and it is concluded that multicenter follow-up linkage studies of complex disorders can help to direct research efforts toward promising regions.


Related Papers

No related papers found

Powered by citation graph analysis